Repository logo
 
Publication

Burnout in the pharmaceutical activity: the impact of COVID-19

dc.contributor.authorSantos, Pedro Machado dos
dc.contributor.authorSilva, Cláudia Ribeiro da
dc.contributor.authorCosta, Diana
dc.contributor.authorTorre, Carla
dc.date.accessioned2022-04-14T09:01:46Z
dc.date.available2022-04-14T09:01:46Z
dc.date.issued2022-01
dc.description.abstractImportance: Pharmacists are among the healthcare professionals involved in the response to the COVID-19 pandemic, maintaining essential services. In the context of restrictions and reorganization of human resources, as a result of policies recently applied to the health sector, following international guidelines, and given the scarcity of data on burnout in pharmaceutical activity, it was considered highly relevant to promote a nationwide survey aiming to collect more complete evidence on the burnout syndrome and to understand how pharmacists have viewed their work and the people they worked closely with. Objectives: The study aimed to assess the occurrence of pharmacist burnout and determine outcomes for each of its dimensions; identify potentially associated characteristics; and determine profiles and critical limits. Design: A cross-sectional observational study conducted by a multidisciplinary panel from the Portuguese Pharmaceutical Society (PPS). Professionals from community and hospital pharmacies who were at the forefront of the COVID-19 response were involved in (i) confirming the need and pertinence for conducting this research, (ii) identifying the main factors leading to pharmaceutical emotional distress (“burnout”), and (iii) disseminating the survey. The questionnaire was designed for digital voluntary, confidential, and anonymous participation and divided into four segments of data collection: (i) demographics, (ii) employment and workplace characterization, (iii) pandemic impact on labor activity, and (iv) burnout assessment (as described ahead). Setting: An electronic survey was addressed to all PPS members, and an account was created solely to manage the questionnaire data for the research team. The web-based and user-friendly platform Google Forms supported the data capture and provided an intuitive interface for validated data entry. Participants: In a population of 15,565 pharmacists (members of the PPS), the minimum recommended sample size (Epi Info software), with a 5% margin of error and a 99.9% confidence interval, should be 1,012 individuals. A total of 1,362 pharmacists participated in the study. Of these, 91.4% (n = 1,246) were involved in direct patient care activity and 7.7% (n = 106) in non-direct patient care activity.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.3389/fpsyt.2021.771462pt_PT
dc.identifier.issn1664-0640
dc.identifier.urihttp://hdl.handle.net/10400.26/40229
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherFrontiers Media S.Apt_PT
dc.subjectCovid-19pt_PT
dc.subjectMaslach burnout inventory,pt_PT
dc.subjectMental healthpt_PT
dc.subjectPharmacistspt_PT
dc.subjectPharmacypt_PT
dc.subjectBurnout profilespt_PT
dc.titleBurnout in the pharmaceutical activity: the impact of COVID-19pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage15pt_PT
oaire.citation.issue20pt_PT
oaire.citation.startPage1pt_PT
oaire.citation.titleFrontiers in Psychiatrypt_PT
oaire.citation.volume12pt_PT
person.familyNameRibeiro da Silva
person.givenNameCláudia
person.identifier.orcid0000-0002-4025-7236
rcaap.rightsrestrictedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication983cf791-272d-4138-8389-bd7c9dee3aa2
relation.isAuthorOfPublication.latestForDiscovery983cf791-272d-4138-8389-bd7c9dee3aa2

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
fpsyt-12-771462.pdf
Size:
1.19 MB
Format:
Adobe Portable Document Format